SEC Form 4 · accession 0001125345-18-000101
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Koenig
Officer — President and CEO · Director
Period of report
Nov 13, 2018
Accepted (ET)
Nov 14, 2018 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 13, 2018 | M | 40,000 | $0.94 | A | 173,163 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) | $0.94 | Nov 13, 2018 | M | 40,000 | D | Jul 11, 2009 | Jan 10, 2019 | Common Stock | 40,000 | 39,897 | D |
Explanation of responses
- F1The transaction represents an exercise and hold of expiring options.